Is your health plan ready for CMS’ Interoperability and Prior Authorization final rule?
With healthcare's ongoing push toward patient-centered care, the Centers for Medicare & Medicaid Services (CMS) has finalized a pivotal regulation that will reshape how health plans handle data exchange and prior authorizations. The CMS Interoperability and Prior Authorization final rule (CMS-0057-F) introduces new requirements that aim to improve patients’ access to their own health data, reduce administrative burdens, and enhance the prior authorization process. With implementation deadlines spanning 2026 and 2027, it's critical for government-sponsored health plans to continue their efforts to ensure compliance.
A new era of healthcare interoperability
The CMS-0057-F Final Rule builds on previous efforts, like the Interoperability and Patient Access Final Rule from 2020. While the earlier rule laid the groundwork by mandating patient data access, this new rule goes further by introducing specific policies for sharing prior authorization information and expanding the role of APIs in health data management. This means health plans will need to adopt new technology, streamline processes, and improve transparency for patients, providers, and other stakeholders.
CMS continues to advance additional interoperability and prior authorization requirements for health plans. One development to watch is the 2026 CMS Interoperability Standards and Prior Authorization for Drugs proposed rule (CMS-0062-P), which would build on CMS-0057-F by extending many of its prior authorization requirements to drugs, along with proposed updates to health IT standards and interoperability API reporting requirements.
Key highlights of the CMS-0057-F final rule:
- Patient and provider access APIs:

